References
- No authors listedU.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study GroupDiabetes19954411124912587589820
- KahnSELachinJMZinmanBEffects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPTDiabetes20116051552156021415383
- AhrénBSchweizerADejagerSVillhauerEBDunningBEFoleyJEMechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humansDiabetes Obes Metab201113977578321507182
- AhrénBFoleyJEImproved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolismDiabetologia201659590791726894277
- SchweizerADejagerSFoleyJEImpact of insulin resistance, body mass index, disease duration, and duration of metformin use on the efficacy of vildagliptinDiabetes Ther201231822736406
- DejagerSRazacSFoleyJESchweizerAVildagliptin in drug-naïve patients with type 2 diabetes: a 24-week, double-blind, randomized, placebo-controlled, multiple-dose studyHorm Metab Res200739321822317373638
- Pi-SunyerFXSchweizerAMillsDDejagerSEfficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetesDiabetes Res Clin Pract200776113213817223217
- BosiECamisascaRPColloberCRochotteEGarberAJEffects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metforminDiabetes Care200730489089517277036
- GarberAJSchweizerABaronMARochotteEDejagerSVildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled studyDiabetes Obes Metab20079216617417300592
- GarberAJFoleyJEBanerjiMAEffects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulfonylureaDiabetes Obes Metab200810111047105618284434
- KothnyWFoleyJKozlovskiPShaoQGallwitzBLukashevichVImproved glycemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitusDiabetes Obes Metab201315325225723039321
- KahnSEHaffnerSMHeiseMAGlycemic durability of rosiglitazone, metformin, or glyburide monotherapyN Engl J Med2006355232427244317145742
- FoleyJEBunckMCPoelmaMBeta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomized controlled trialDiabetologia20115481985199121547496
- FoleyJELiqueros-SaylanMHeYLEffect of vildagliptin on glucagon secretion during meals in patients with type 1 diabetesHorm Metab Res2008401072773018597213